TMO

Thermo Fisher Scientific
D

TMO

Arincen67/100B
706.32
USD
7.96
(1.14%)
Post Trading·709.98USD+3.66(+0.52%)
Last updated: · Delayed 15 min
Fair value599.09Plus+18%433Price 706.32754
Q4 FY2026 · Earnings report
EPS estimate 7.13Revenue estimate 12.84B
OverviewFinancialsForecastEarningsDividendsCompany

Thermo Fisher Scientific executives and insider trading

Marc N. Casper sold 69,041 shares for 39.91M USD in 117 sales over the last twelve months, the last on 24 August 2026, and bought none on the open market.

Over the last twelve months Thermo Fisher Scientific's insiders sold 240,314 shares for 140.41M USD in 141 sales on the open market, and bought 0 shares in 0 purchases.

Insiders over the last twelve months

Insider sales
141
Shares sold
240,314
Value sold
140.41M USD
Insider purchases
0

Insiders buying against selling

Bought on the market
Sold on the market
0
1 week
0
0
1 month
2.00M USD
0
3 months
54.64M USD
0
6 months
63.49M USD
0
1 year
140.41M USD
11.04K USD
2 years
229.38M USD
Sold, decided at the timeSold under a Rule 10b5-1 plan set in advance

Open-market purchases and sales reported on Form 4, by value. Awards, option exercises and shares withheld for tax are not counted. Whether a sale was under a Rule 10b5-1 plan is read from each Form 4 at the SEC (the box exists on filings since April 2023).

Executives and directors

The people who run the company and the directors who reported trades, with what each bought and sold on the open market over the last twelve months. The CEO first, then whoever traded most.

NamePositionAgeShares sold (12 months)Value sold (12 months)Shares bought (12 months)Last saleShares held after
Marc N. Casper CEOChairman & CEO5869,04139.91M USD—24 Aug 2026123,201
Michel Lagarde Executive Vice President—88,68451.31M USD—4 Dec 202585,511
Lisa Britt Chief Human Resources Officer & Senior Vice President5831,40418.87M USD—28 Oct 202611,560
Michael D Shafer Executive Vice President—29,35717.45M USD—11 Aug 202620,832
Frederick M. Lowery Executive Vice President—13,8258.15M USD—2 Dec 202515,830
Gianluca Pettiti President, COO & President of Products and Technologies477,5834.47M USD—31 Aug 202626,949
Joseph R. Holmes Vice President & Chief Accounting Officer46420245.62K USD—7 Aug 20262,956

Insider sales and purchases by quarter

How many insider sales and purchases were reported each quarter.

Insider sales Insider purchases

Every insider transaction

Insiders must report every trade in the company's shares to the SEC within two business days, on Form 4. Only purchases and sales are trades on the open market; awards, option exercises, shares withheld for tax and gifts come with pay, and the twelve-month totals leave them out.

DateNameTransactionSharesPriceValueShares held afterFiling
28 Oct 2026Lisa BrittSale2,831706.452.00M USD11,560Form 4
31 Aug 2026Gianluca PettitiSale3,733614.382.29M USD23,216Form 4
31 Aug 2026Gianluca PettitiSale400614.38245.75K USD23,216Form 4
24 Aug 2026Marc N. CasperSale101625.4163.17K USD124,099Form 4
24 Aug 2026Marc N. CasperSale33626.5920.68K USD124,066Form 4
24 Aug 2026Marc N. CasperSale79628.0149.61K USD123,987Form 4
24 Aug 2026Marc N. CasperSale62628.7438.98K USD123,925Form 4
21 Aug 2026Marc N. CasperSale2,727625.461.71M USD131,198Form 4
21 Aug 2026Marc N. CasperSale3,014626.511.89M USD128,184Form 4
21 Aug 2026Marc N. CasperSale1,791627.391.12M USD126,393Form 4
21 Aug 2026Marc N. CasperSale2,147628.611.35M USD124,246Form 4
21 Aug 2026Marc N. CasperSale321629.10201.94K USD123,925Form 4
20 Aug 2026Marc N. CasperSale909625.45568.53K USD133,016Form 4
20 Aug 2026Marc N. CasperSale821626.83514.63K USD132,195Form 4
20 Aug 2026Marc N. CasperSale1,314627.66824.75K USD130,881Form 4

Common questions about Thermo Fisher Scientific's executives and insiders

Source: Financial Modeling Prep

Smarter Decisions,Together
FacebookTwitterYoutubeInstagramLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.